The paper investigates the molecular basis for acquired therapeutic resistance in KRAS-mutant colorectal cancer (CRC) following dual inhibition of KRAS and EGFR. The research establishes that CRC cells utilize lineage plasticity, adopting a secretory Paneth-like cell state to survive the targeted therapy. Mechanistically, this adaptive transition is orchestrated by the SMAD1-FGFR3 signaling axis, ...去小宇宙查看完整单集简介
前往小宇宙评论区与主播互动
前往小宇宙评论区与主播互动
Fler avsnitt av Paper Talk
Visa alla avsnitt av Paper TalkPaper Talk med 淼淼Elva finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
